67,870 Shares in Encompass Health Co. (NYSE:EHC) Bought by ExodusPoint Capital Management LP

ExodusPoint Capital Management LP purchased a new stake in shares of Encompass Health Co. (NYSE:EHC) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund purchased 67,870 shares of the company’s stock, valued at approximately $6,268,000. ExodusPoint Capital Management LP owned about 0.07% of Encompass Health as of its most recent filing with the SEC.

A number of other hedge funds have also modified their holdings of the company. TD Private Client Wealth LLC boosted its position in Encompass Health by 2,870.0% in the third quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company’s stock valued at $709,000 after buying an additional 7,089 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Encompass Health by 0.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 644,764 shares of the company’s stock valued at $59,544,000 after acquiring an additional 4,345 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Encompass Health by 1.2% in the third quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock worth $161,781,000 after acquiring an additional 20,547 shares during the period. Central Pacific Bank Trust Division increased its stake in shares of Encompass Health by 15.1% in the fourth quarter. Central Pacific Bank Trust Division now owns 3,195 shares of the company’s stock worth $295,000 after acquiring an additional 418 shares during the period. Finally, Merit Financial Group LLC purchased a new position in shares of Encompass Health during the fourth quarter worth $374,000. 97.25% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at $6,798,129.56. The trade was a 6.79 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.10% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Barclays increased their price target on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, February 7th. StockNews.com lowered Encompass Health from a “buy” rating to a “hold” rating in a report on Thursday. William Blair reissued an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. KeyCorp upped their price objective on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Monday, February 10th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $110.00 target price on shares of Encompass Health in a report on Tuesday, February 11th. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $107.67.

Encompass Health Price Performance

Encompass Health stock opened at $98.14 on Friday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The company’s fifty day moving average price is $99.25 and its 200 day moving average price is $97.71. The stock has a market capitalization of $9.88 billion, a P/E ratio of 22.00, a P/E/G ratio of 2.31 and a beta of 0.87. Encompass Health Co. has a 1 year low of $78.53 and a 1 year high of $104.55.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, equities research analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health’s dividend payout ratio is presently 15.25%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.